Female shock patients face delays in treatment and are less likely to receive approved interventions, says Suzanne Baron.

Interventional cardiologists share insights into the progress of procedures and devices such as Impella and TAVI for acute ...

SGMC Health has successfully performed its first procedure using the Abiomed Impella 5.5 with SmartAssist, a minimally ...

EMJ spoke with Srihari S. Naidu, who shared insights into his pioneering work in alcohol septal ablation, his contributions ...

The 2025 Men's Royal Rumble Match was by far the most anticipated match on the card. The WWE assembled a stacked lineup of superstars and legends for the Men's titular bout, including John Cena ...

Please provide your email address to receive an email when new articles are posted on . Two heart pump systems were approved for the treatment of acute decompensated HF and cardiogenic shock in ...

Objective We investigated the benefit of Impella, a modern percutaneous mechanical support (pMCS) device, versus former standard intra-aortic balloon pump (IABP) in acute myocardial infarction ...

WASHINGTON, D.C.—Johnson & Johnson MedTech’s Abiomed announced that its compressible, expandable heart pump has cleared a pivotal trial, and it’s now headed for FDA review in the coming months.

That “everything” includes a cardiogenic shock, a gastrointestinal bleed ... learned about a cutting edge technology called the Impella, a temporary heart pump. “They actually flew the ...

She also drew attention to the Impella trial that gave half of patients with MI-related cardiogenic shock a microaxial flow pump (Impella CP) in addition to standard of care. "This is another ...